TrialCancer control : journal of the Moffitt Cancer Center

Biweekly Raltitrexed Combined With Irinotecan as Second-Line Therapy for Patients With Metastatic Colorectal Cancer: A Phase II Trial.

Ke Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.